Iguratimod is an anti-rheumatic agent.
The main mechanism of action of iguratimod is: by selectively inhibiting cyclooxygenase-2, thereby reducing the production of prostaglandins in inflammatory tissues, inhibiting the release of bradykinins in inflammatory tissues, inhibiting antigen-specific T cell proliferation, reducing the level of pro-inflammatory factors produced by B cells in patients with rheumatoid arthritis, stimulating osteoblast differentiation and bone construction, inhibiting synovial cell co-stimulating factor expression and cytokine production. It can inhibit the production of immunoglobulins, inhibit cytokine production, inhibit bone resorption and promote bone formation.
|Appearance||White crystalline powder||Complies|
|Loss on Drying||≤0.5%||0.21%|
|Appearance:||White crystalline powder|
|Package details:||100g/bottle; 1kg/foil bag|
Iguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!